Nanobiotix SA - ADRNBTX
13F holders, Q3 2025 (September 30)11holders +1
1new positions
0sold out
$18.89avg. 13F price*
At the end of Q3 2025, 11 institutions reported holding Nanobiotix SA - ADR (NBTX) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Johnson & Johnson ($106.2M), Geode Capital Management, LLC ($192K) and Optiver Holding B.V. ($101K).
- Company
- Nanobiotix SA - ADR
- CUSIP
- 63009J107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $101K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 5,356 shares bought and 5,543 shares sold, net −187 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Johnson & Johnson | 21.08% | No change | 5,623,816 | $106.2M |
| Geode Capital Management, LLC | 0.00% | No change | 10,184 | $192K |
| Optiver Holding B.V. | 0.00% | New | 5,356 | $101K |
| Morgan Stanley | 0.00% | Reduce -55.1% | 2,378 | $45K |
| UBS Group AG | 0.00% | Reduce -51.1% | 2,161 | $41K |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -0.6% | 514 | $10K |
| BNP Paribas Financial Markets | 0.00% | Reduce -47.4% | 400 | $8K |
| Royal Bank of Canada | 0.00% | No change | 125 | $2K |
| Rhumbline Advisers | 0.00% | No change | 33 | $623 |
| National Bank of Canada | 0.00% | No change | 13 | $245 |
| Barclays PLC | 0.00% | No change | 4 | $76 |
"% of holder's portfolio" is NBTX's weight in each manager's 13F, not the share of Nanobiotix SA - ADR the manager owns.